Literature DB >> 12748496

Combined use of magnetic resonance imaging, CA 125 assay, histologic type, and histologic grade in the prediction of lymph node metastasis in endometrial carcinoma.

Yukiharu Todo1, Noriaki Sakuragi, Ryutaro Nishida, Takashi Yamada, Yasuhiko Ebina, Ritsu Yamamoto, Seiichiro Fujimoto.   

Abstract

OBJECTIVE: The aim of this study was to predict retroperitoneal lymph node metastasis during the preoperative examination of patients with endometrial carcinoma and to determine whether lymphadenectomy must be performed. STUDY
DESIGN: This study was carried out on 214 patients with endometrial carcinoma. Preoperative evaluators were volume index, depth of myometrial invasion (as assessed by magnetic resonance imaging), serum CA 125 level, histologic type, and histologic grade. With the use of receiver operating characteristic curves, cutoff values of volume index and serum CA 125 levels were determined. The relationships of these evaluators with pelvic lymph node metastasis were investigated by multivariate analysis with a logistic regression model. The relationships of these evaluators with para-aortic lymph node metastasis were investigated in the same way.
RESULTS: Histologic type, volume index, histologic grade, and serum CA 125 level were found to be independent risk factors for pelvic lymph node metastasis; serum CA 125 level and volume index were found to be independent risk factors for para-aortic lymph node metastasis. Among 110 cases with no risk factors for pelvic lymph node metastasis, pelvic lymph node metastasis was observed in 4 cases (3.6%). On the other hand, only 1 case of 128 cases (0.7%) with no risk factors for para-aortic lymph node metastasis actually had metastasis.
CONCLUSION: Careful consideration of the possibility of the elimination of the requirement of retroperitoneal lymphadenectomy is needed in cases with no risk factors for lymph node metastasis. However, our results suggest that para-aortic lymphadenectomy may not be necessary in cases with no risk factors for para-aortic lymph node metastasis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12748496     DOI: 10.1067/mob.2003.318

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  21 in total

1.  Diagnostic Accuracy of Clinical Biomarkers for Preoperative Prediction of Lymph Node Metastasis in Endometrial Carcinoma: A Systematic Review and Meta-Analysis.

Authors:  Casper Reijnen; Joanna IntHout; Leon F A G Massuger; Fleur Strobbe; Heidi V N Küsters-Vandevelde; Ingfrid S Haldorsen; Marc P L M Snijders; Johanna M A Pijnenborg
Journal:  Oncologist       Date:  2019-06-11

2.  Is mucinous adenocarcinoma of the endometrium a risk factor for lymph node involvement? A multicenter case-control study.

Authors:  Kemal Gungorduk; Aykut Ozdemir; Ibrahim Egemen Ertas; Ilker Selcuk; Ulas Solmaz; Emre Ozgu; Emre Mat; Mehmet Gokcu; Tuba Karadeniz; Serap Akbay; Muzaffer Sanci; Mehmet Mutlu Meydanli; Duygu Ayaz; Tayfun Gungor
Journal:  Int J Clin Oncol       Date:  2014-11-08       Impact factor: 3.402

Review 3.  Role of pelvic and para-aortic lymphadenectomy in endometrial cancer: current evidence.

Authors:  Giorgio Bogani; Sean C Dowdy; William A Cliby; Fabio Ghezzi; Diego Rossetti; Andrea Mariani
Journal:  J Obstet Gynaecol Res       Date:  2014-02       Impact factor: 1.730

4.  Project for the National Program of Early Diagnosis of Endometrial Cancer Part I.

Authors:  R E Bohîlțea; V Ancăr; M M Cirstoiu; V Rădoi; L C Bohîlțea; F Furtunescu
Journal:  J Med Life       Date:  2015 Jul-Sep

Review 5.  Diagnostic accuracy of preoperative tests for lymph node status in endometrial cancer: a systematic review.

Authors:  H M P Pelikan; J W Trum; F C H Bakers; R G H Beets-Tan; L J M Smits; R F P M Kruitwagen
Journal:  Cancer Imaging       Date:  2013-07-22       Impact factor: 3.909

6.  Preoperative selection of endometrial cancer patients at low risk for lymph node metastases: useful criteria for enrollment in clinical trials.

Authors:  Mariam M AlHilli; Andrea Mariani
Journal:  J Gynecol Oncol       Date:  2014-10       Impact factor: 4.401

7.  Lymphadenectomy can be omitted for low-risk endometrial cancer based on preoperative assessments.

Authors:  Takashi Mitamura; Hidemichi Watari; Yukiharu Todo; Tatsuya Kato; Yosuke Konno; Masayoshi Hosaka; Noriaki Sakuragi
Journal:  J Gynecol Oncol       Date:  2014-06-18       Impact factor: 4.401

8.  Utility of Preoperative CA125 Assay in the Management Planning of Women Diagnosed with Uterine Cancer.

Authors:  N Povolotskaya; N Das; K Dhar; D Brinkmann; F Gardner; R Woolas
Journal:  Surg Res Pract       Date:  2014-02-27

9.  Long-term outcomes of magnetic resonance imaging-invisible endometrial cancer.

Authors:  Hyun Jin Choi; Sunyoung Lee; Byung Kwan Park; Tae Joong Kim; Chan Kyo Kim; Jung Jae Park; Chel Hun Choi; Yoo Young Lee; Jeong Won Lee; Duk Soo Bae; Byoung Gie Kim
Journal:  J Gynecol Oncol       Date:  2016-04-18       Impact factor: 4.401

Review 10.  Predictive value of preoperative serum CA-125 levels in patients with uterine cancer: The Asian experience 2000 to 2012.

Authors:  Bruce Patsner; Ga Won Yim
Journal:  Obstet Gynecol Sci       Date:  2013-09-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.